Salbutamol 400mcg

DRUG2 trials

Sponsors

Syntara, University of Alberta

Conditions

HealthyLung Diseases, Obstructive

Phase 1

Cardiovascular Consequences of Inhaled Short-acting Beta-agonist Use

CompletedNCT06027606

University of AlbertaHealthy

Start: 2023-09-01End: 2025-09-25Updated: 2025-11-18

Phase 2

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

CompletedNCT00117182

SyntaraLung Diseases, Obstructive

Start: 2005-07-31End: 2006-08-31Target: 140Updated: 2016-04-20